943189-21-7Relevant articles and documents
Heterocyclic compounds as FGFR4 inhibitors
-
, (2021/02/10)
The present invention provides heterocyclic compounds as selective inhibitors of fibroblast growth factor receptor 4 (FGFR4), pharmaceutical compositions containing the compounds, methods of preparingthe compounds, and methods of treating cell proliferative diseases, such as cancer, using the compounds of the invention.
BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS
-
, (2016/09/15)
The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR4 enzyme and are useful in the treatment of FGFR4-associated diseases such as cancer.
FGFR4 INHIBITORS
-
, (2016/10/31)
We provide FGFR inhibitors, their salts, methods of manufacture, and methods of use.